Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hofmeister Robert
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Weis Holger
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Vieser Jaime
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Postma Robert W
Alaunos Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Groenewald Ferdinand
Alaunos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Discovery Capital Management, LLC(1.66%),Robert K. Citrone(1.66%), etc.
Alaunos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MSD Partners, L.P.(9.2%),MSD Credit Opportunity Master Fund, L.P.(9.2%), etc.
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hogue Dale Curtis Jr.
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hogue Dale Curtis Jr.
Alaunos Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Hogue Dale Curtis Jr.
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Boyle Kevin S. Sr.
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Postma Robert W
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hofmeister Robert
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thistle Mary
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Huang James
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Vieser Jaime
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Weis Holger
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hofmeister Robert
Alaunos Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Hofmeister Robert
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Srivastava Abhishek K
No Data